The authors reply

New England Journal of Medicine

Volumn 371, Issue 19, 2014, Pages 1847-1848

  George, James N ^a   Nester, Carla M ^b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT INHIBITOR; HOMOCYSTEINE; IMMUNOGLOBULIN G; METHIONINE; METHYLMALONIC ACID;

ANTICOMPLEMENT THERAPY; BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL FEATURE; COBALAMIN C DEFICIENCY; HEMOLYTIC UREMIC SYNDROME; HOMOCYSTEINE BLOOD LEVEL; HUMAN; IMMUNOADSORPTION; IMMUNOGLOBULIN G DEPLETION; IMMUNOTHERAPY; KIDNEY INJURY; LABORATORY DIAGNOSIS; LETTER; METHIONINE BLOOD LEVEL; METHYLMALONIC ACIDURIA; NEUROLOGIC DISEASE; NUTRITIONAL DEFICIENCY; PLASMAPHERESIS; PNEUMOCOCCAL INFECTION; SEPSIS; SHIGA TOXIN MEDIATED HEMOLYTIC UREMIC SYNDROME; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE; NOTE;

HUMANS; THROMBOTIC MICROANGIOPATHIES;

EID: 84908590395     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1410951     Document Type: Letter

References (2)

1. Greinacher A, Friesecke S, Abel P, et al. Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial. Lancet 2011;378:1166-73.
2. Cornec-Le Gall E, Delmas Y, De Parscau L, et al. Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency. Am J Kidney Dis 2014;63:119-23.